According to this study, Global Tardive Dyskinesia (TD) Treatment market size will reach US$ million by 2031.

Global Tardive Dyskinesia (TD) Treatment Market Size and Outlook 2025-31

According to this study, the global Tardive Dyskinesia (TD) Treatment market size will reach US$ million by 2031. Tardive dyskinesia (TD) treatment includes medical interventions and therapies used to manage the involuntary and repetitive movements associated with tardive dyskinesia, a side effect of certain medications. The market for tardive dyskinesia treatment is driven by the demand for effective and safe treatments to alleviate the symptoms of TD and improve patients quality of life. The markets growth is also influenced by ongoing research in neurology and the development of targeted therapies for movement disorders. LPI (LP Information) newest research report, the Tardive Dyskinesia (TD) Treatment Industry Forecast looks at past sales and reviews total world Tardive Dyskinesia (TD) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Tardive Dyskinesia (TD) Treatment sales for 2025 through 2031. With Tardive Dyskinesia (TD) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tardive Dyskinesia (TD) Treatment industry. This Insight Report provides a comprehensive analysis of the global Tardive Dyskinesia (TD) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tardive Dyskinesia (TD) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Tardive Dyskinesia (TD) Treatment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tardive Dyskinesia (TD) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tardive Dyskinesia (TD) Treatment. This report presents a comprehensive overview, market shares, and growth opportunities of Tardive Dyskinesia (TD) Treatment market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Valbenazine &nbsp;&nbsp;&nbsp; Amantadine &nbsp;&nbsp;&nbsp; Tetrabenazine &nbsp;&nbsp;&nbsp; Clonazepam Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Clinics &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Teva Pharma &nbsp;&nbsp;&nbsp; Biogen &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; Neurocrine Biosciences &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Bayer AG

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Tardive Dyskinesia (TD) Treatment Market Size (2020-2031) &nbsp;2.1.2 Tardive Dyskinesia (TD) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Tardive Dyskinesia (TD) Treatment by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Tardive Dyskinesia (TD) Treatment Segment by Type &nbsp;2.2.1 Valbenazine &nbsp;2.2.2 Amantadine &nbsp;2.2.3 Tetrabenazine &nbsp;2.2.4 Clonazepam &nbsp;2.3 Tardive Dyskinesia (TD) Treatment Market Size by Type &nbsp;2.3.1 Tardive Dyskinesia (TD) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Tardive Dyskinesia (TD) Treatment Market Size Market Share by Type (2020-2025) &nbsp;2.4 Tardive Dyskinesia (TD) Treatment Segment by Application &nbsp;2.4.1 Hospitals &nbsp;2.4.2 Clinics &nbsp;2.4.3 Others &nbsp;2.5 Tardive Dyskinesia (TD) Treatment Market Size by Application &nbsp;2.5.1 Tardive Dyskinesia (TD) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Tardive Dyskinesia (TD) Treatment Market Size Market Share by Application (2020-2025) 3 Tardive Dyskinesia (TD) Treatment Market Size by Player &nbsp;3.1 Tardive Dyskinesia (TD) Treatment Market Size Market Share by Player &nbsp;3.1.1 Global Tardive Dyskinesia (TD) Treatment Revenue by Player (2020-2025) &nbsp;3.1.2 Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Tardive Dyskinesia (TD) Treatment Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Tardive Dyskinesia (TD) Treatment by Region &nbsp;4.1 Tardive Dyskinesia (TD) Treatment Market Size by Region (2020-2025) &nbsp;4.2 Global Tardive Dyskinesia (TD) Treatment Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Tardive Dyskinesia (TD) Treatment Market Size Growth (2020-2025) &nbsp;4.4 APAC Tardive Dyskinesia (TD) Treatment Market Size Growth (2020-2025) &nbsp;4.5 Europe Tardive Dyskinesia (TD) Treatment Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Tardive Dyskinesia (TD) Treatment Market Size by Country (2020-2025) &nbsp;5.2 Americas Tardive Dyskinesia (TD) Treatment Market Size by Type (2020-2025) &nbsp;5.3 Americas Tardive Dyskinesia (TD) Treatment Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Tardive Dyskinesia (TD) Treatment Market Size by Region (2020-2025) &nbsp;6.2 APAC Tardive Dyskinesia (TD) Treatment Market Size by Type (2020-2025) &nbsp;6.3 APAC Tardive Dyskinesia (TD) Treatment Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2020-2025) &nbsp;7.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2020-2025) &nbsp;7.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment by Region (2020-2025) &nbsp;8.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Tardive Dyskinesia (TD) Treatment Market Forecast &nbsp;10.1 Global Tardive Dyskinesia (TD) Treatment Forecast by Region (2026-2031) &nbsp;10.1.1 Global Tardive Dyskinesia (TD) Treatment Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.1.3 APAC Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.1.4 Europe Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.1.5 Middle East & Africa Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.2 Americas Tardive Dyskinesia (TD) Treatment Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.2.2 Canada Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.2.3 Mexico Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.2.4 Brazil Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.3 APAC Tardive Dyskinesia (TD) Treatment Forecast by Region (2026-2031) &nbsp;10.3.1 China Tardive Dyskinesia (TD) Treatment Market Forecast &nbsp;10.3.2 Japan Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.3.3 Korea Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.3.4 Southeast Asia Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.3.5 India Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.3.6 Australia Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.4 Europe Tardive Dyskinesia (TD) Treatment Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.4.2 France Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.4.3 UK Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.4.4 Italy Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.4.5 Russia Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.5 Middle East & Africa Tardive Dyskinesia (TD) Treatment Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.5.2 South Africa Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.5.3 Israel Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.5.4 Turkey Market Tardive Dyskinesia (TD) Treatment Forecast &nbsp;10.6 Global Tardive Dyskinesia (TD) Treatment Forecast by Type (2026-2031) &nbsp;10.7 Global Tardive Dyskinesia (TD) Treatment Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Tardive Dyskinesia (TD) Treatment Forecast 11 Key Players Analysis &nbsp;11.1 Teva Pharma &nbsp;11.1.1 Teva Pharma Company Information &nbsp;11.1.2 Teva Pharma Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.1.3 Teva Pharma Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Teva Pharma Main Business Overview &nbsp;11.1.5 Teva Pharma Latest Developments &nbsp;11.2 Biogen &nbsp;11.2.1 Biogen Company Information &nbsp;11.2.2 Biogen Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.2.3 Biogen Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Biogen Main Business Overview &nbsp;11.2.5 Biogen Latest Developments &nbsp;11.3 Johnson & Johnson &nbsp;11.3.1 Johnson & Johnson Company Information &nbsp;11.3.2 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.3.3 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Johnson & Johnson Main Business Overview &nbsp;11.3.5 Johnson & Johnson Latest Developments &nbsp;11.4 GlaxoSmithKline &nbsp;11.4.1 GlaxoSmithKline Company Information &nbsp;11.4.2 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.4.3 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 GlaxoSmithKline Main Business Overview &nbsp;11.4.5 GlaxoSmithKline Latest Developments &nbsp;11.5 Neurocrine Biosciences &nbsp;11.5.1 Neurocrine Biosciences Company Information &nbsp;11.5.2 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.5.3 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Neurocrine Biosciences Main Business Overview &nbsp;11.5.5 Neurocrine Biosciences Latest Developments &nbsp;11.6 Pfizer &nbsp;11.6.1 Pfizer Company Information &nbsp;11.6.2 Pfizer Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.6.3 Pfizer Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Pfizer Main Business Overview &nbsp;11.6.5 Pfizer Latest Developments &nbsp;11.7 Novartis &nbsp;11.7.1 Novartis Company Information &nbsp;11.7.2 Novartis Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.7.3 Novartis Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Novartis Main Business Overview &nbsp;11.7.5 Novartis Latest Developments &nbsp;11.8 Sanofi &nbsp;11.8.1 Sanofi Company Information &nbsp;11.8.2 Sanofi Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.8.3 Sanofi Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Sanofi Main Business Overview &nbsp;11.8.5 Sanofi Latest Developments &nbsp;11.9 AstraZeneca &nbsp;11.9.1 AstraZeneca Company Information &nbsp;11.9.2 AstraZeneca Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.9.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 AstraZeneca Main Business Overview &nbsp;11.9.5 AstraZeneca Latest Developments &nbsp;11.10 Bayer AG &nbsp;11.10.1 Bayer AG Company Information &nbsp;11.10.2 Bayer AG Tardive Dyskinesia (TD) Treatment Product Offered &nbsp;11.10.3 Bayer AG Tardive Dyskinesia (TD) Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Bayer AG Main Business Overview &nbsp;11.10.5 Bayer AG Latest Developments 12 Research Findings and Conclusion

Report	Global Tardive Dyskinesia (TD) Treatment Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI23197

Buyer Information

Order Summary